BC
IPSC icon

Boxer Capital’s Century Therapeutics IPSC Stock Holding History

Boxer Capital’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,900,000
Closed -$6.67M – 22
2024
Q3 		$6.67M Sell
3,900,000
-1,001,603
-20% -$1.96M 0.33% 47
2024
Q2 		$12.5M Buy
4,901,603
+3,151,603
+180% +$9.96M 0.66% 38
2024
Q1 		$7.32M Buy
+1,750,000
New +$7.41M 0.36% 46

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boxer Capital's IPSC Position: Q4 2024 in Review

Boxer Capital sold out of Century Therapeutics (IPSC) in Q4 2024, closing a stake of 3,900,000 shares — an estimated $6.67M sold.

Boxer Capital first reported a position in IPSC in Q1 2024 and held it in 3 quarters. The position peaked at $12.5M in Q2 2024. 72 funds tracked by Wall St. Rank hold IPSC as of Q4 2024.

  • Boxer Capital reported no remaining Century Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 3,900,000 Century Therapeutics shares in Q4 2024, an estimated $6.67M.
  • Boxer Capital first reported a position in Century Therapeutics in Q1 2024 and held it in 3 quarters.
  • Boxer Capital's Century Therapeutics position peaked at $12.5M in Q2 2024.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.